Refsum's Disease-Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder

Refsum's Disease is an inherited metabolic disorder in which a metabolite of branched chain fatty acids accumulates due to lack of appropriate oxidative enzymes. Patients have elevated plasma phytanic acid levels and high concentrations of phytanic acid in a variety of tissues leading to progre...

Full description

Saved in:
Bibliographic Details
Main Authors: Nimalie J. Perera (Author), Barry Lewis (Author), Huy Tran (Author), Michael Fietz (Author), David R. Sullivan (Author)
Format: Book
Published: Hindawi Limited, 2011-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!